Usefulness of Macular Thickness Derived from Spectral-domain Optical Coherence Tomography in the Detection of Glaucoma Progression
Overview
Affiliations
Purpose: To assess the reproducibility of circumpapillary retinal nerve fiber layer thickness (cRNFLT) and total macular thickness (TMT) parameters using Cirrus spectral domain optical coherence tomography (SD-OCT) and to apply this information to investigate its ability to detect cases where visual field (VF) progression was noted on event-based analysis in the eyes with early glaucomatous VF loss.
Methods: Intraclass correlation coefficient (ICC), coefficient of variation (COV), and intersession test-retest variability were calculated from the control group. The sensitivity and specificity of SD-OCT for the identification of progressive VF defects were tested on progressive and stable patients.
Results: All ICCs from cRNFLT and TMT measurements ranged from 94.8% to 99.0%. While average cRNFLT showed the lowest intersession COV (2.57%), the nasal-outer and superior-inner TMT sectors showed the lowest COV (0.96%). The sensitivities of Cirrus SD-OCT cRNFLT measurements ranged from 37.8% to 48.9%, while that of TMT measurement was 73.3% when tested at the 95% confidence interval (CI). The sensitivity for detecting progressive VF changes in the central 10° area improved to 84.8% with TMT measurement, while it remained unchanged with cRNFLT measurements. The agreement on progression detection between cRNFLT and TMT sector measurements was poor (κ = 0.072 for overall, and 0.102 for the central 10° area at 95% CI, respectively).
Conclusions: Intersession measurements of both cRNFLT and TMT parameters with Cirrus SD-OCT showed excellent reproducibility. TMT parameters using Cirrus SD-OCT may be better than cRNFLT measurements in terms of detecting progressive VF loss. This sensitivity derived from TMT measurements increased when progressive VF loss occurred in the central 10° area.
A Model of Progression to Help Identify Macular Damage Due to Glaucoma.
Hood D, La Bruna S, Leshno A, Gomide G, Kim M, Cioffi G Invest Ophthalmol Vis Sci. 2023; 64(15):8.
PMID: 38060217 PMC: 10709805. DOI: 10.1167/iovs.64.15.8.
Association Between Rate of Ganglion Cell Complex Thinning and Rate of Central Visual Field Loss.
Mahmoudinezhad G, Moghimi S, Nishida T, Latif K, Yamane M, Micheletti E JAMA Ophthalmol. 2022; 141(1):33-39.
PMID: 36416837 PMC: 9856692. DOI: 10.1001/jamaophthalmol.2022.4973.
Mohammadzadeh V, Su E, Shi L, Coleman A, Law S, Caprioli J Ophthalmol Sci. 2022; 2(3):100187.
PMID: 36245763 PMC: 9559093. DOI: 10.1016/j.xops.2022.100187.
Ganglion Cell Complex: The Optimal Measure for Detection of Structural Progression in the Macula.
Mohammadzadeh V, Su E, Rabiolo A, Shi L, Zadeh S, Law S Am J Ophthalmol. 2021; 237:71-82.
PMID: 34942111 PMC: 9035060. DOI: 10.1016/j.ajo.2021.12.009.
Estimating Ganglion Cell Complex Rates of Change With Bayesian Hierarchical Models.
Mohammadzadeh V, Su E, Zadeh S, Law S, Coleman A, Caprioli J Transl Vis Sci Technol. 2021; 10(4):15.
PMID: 34003991 PMC: 8054624. DOI: 10.1167/tvst.10.4.15.